EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)

EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)

Objective. To evaluate the effectiveness and tolerance of Etanercept (ETN) therapy in patients with rheumatoid arthritis (RA).Material and Methods. 188 adult patients with severe and moderate RA (average DAS28 score of 6.26±0.89) subcutaneously received 50 mg/wk ETC during 24 wk along with therapy u...

Full description

Bibliographic Details
Main Authors:	Anna Olegovna Pchelintseva, E Yu Panasyuk, O F Ryabitseva, V I Mazurov, I G Salikhov, A E Sizikov, O N Ivanova, V N Sorotskaya, O V Semagina, I V Vinogradova, A I Kulikov, L N Denisov, E L Nasonov
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2014-02-01
Series:	Научно-практическая ревматология
Subjects:	rheumatoid arthritis etanercept das28 acr20/50/70 sdai cdai
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1346

Similar Items

IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS
by: Anastasia Sergeevna Avdeeva, et al.
Published: (2012-10-01)

Evaluation of the clinical efficiency of tocilizumab therapy, by using DAS 28, SDAI, CDAI indices and new 2011 EULAR/ACR remission criteria in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-04-01)

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-08-01)

Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis
by: A S Avdeeva, et al.
Published: (2013-05-01)

Clinical efficacy of the rituximab biosimilar Acellbia® 600 mg in patients with active rheumatoid arthritis in clinical practice
by: D. A. Kusevich, et al.
Published: (2019-01-01)

Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients?
by: K. El-Hadidi, et al.
Published: (2020-01-01)

Azilsartan improves the effects of etanercept in patients with active rheumatoid arthritis: a pilot study
by: Mahmood NMA, et al.
Published: (2018-08-01)

CHANGES IN CALPROTECTIN LEVEL, ITS RELATIONSHIP TO THE CLINICAL AND LABORATORY PARAMETERS OF DISEASE ACTIVITY AND SIGNIFICANCE FOR PREDICTING THE THERAPEUTIC RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ETANERCEPT
by: A. O. Pchelintseva, et al.
Published: (2015-09-01)

ASSESSMENT OF RHEUMATOID ARTHRITIS ACTIVITY DURING PREGNANCY AND POSTPARTUM
by: E. V. Matyanova, et al.
Published: (2015-04-01)

Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)
by: E Yu Panasyuk, et al.
Published: (2013-04-01)

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-06-01)

Evaluation of Efficacy and Safety of Etanercept and Etanercept + Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis without Systemic Manifestations
by: T. M. Bzarova, et al.
Published: (2016-01-01)

Experience of etanercept treatment in juvenile ankylosing spondyloarthritis
by: A. N. Fetisova, et al.
Published: (2013-03-01)

USE OF ETANERCEPT IN JUVENILLE ANKYLOSING SPONDILLO-ARTHRITIS WITH EARLY ONSET
by: A. N. Fetisova, et al.
Published: (2012-03-01)

Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritis
by: Brian C. Sauer, et al.
Published: (2020-10-01)

USE OF ETANERCEPT IN PATIENTS WITH OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
by: Т. М. Bzarova, et al.
Published: (2014-12-01)

Nail Lichen Planus: Successful Treatment with Etanercept
by: N. Irla, et al.
Published: (2010-10-01)

Evaluation of effectiveness and safety of Etanercept in children with Juvenile psoriatic arthritis
by: K. V. Aleksanyan, et al.
Published: (2020-09-01)

LONG TERM FOLLOW-UP ON EFFECTIVENESS AND SAFETY OF ETANERCEPT IN JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS
by: A. A. Baranov, et al.
Published: (2015-04-01)

EFFICACY OF ETANERCEPT IN TREATMENT OF VARIOUS TYPES OF JUVENILE IDIOPATHIC ARTHRITIS
by: O. Yu. Konopel'ko, et al.
Published: (2013-12-01)

CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS
by: O. A. Rumyantseva, et al.
Published: (2018-05-01)

ASSESSMENT OF THE QUALITY OF LIFE OF PATIENTS WITH THE JUVENILE IDIOPATHIC ARTHRITIS TREATED BY THE ETANERCEPT
by: A. N. Fetisova, et al.
Published: (2014-07-01)

ETANERCEPT IN THE REAL CLINICAL PRACTICE OF TREATMENT IN PATIENTS WITH ACTIVE JUVENILE IDIOPATHIC ARTHRITIS
by: Elena Spartakovna Zholobova, et al.
Published: (2013-02-01)

Off-label uses of etanercept in dermatology
by: Andrés Tirado-Sánchez, et al.
Published: (2016-01-01)

Evaluation of Efficacy and Safety of Etanercept Therapy in Patients with Early and Late Juvenile Idiopathic Arthritis without Systemic Manifestations
by: T. M. Bzarova, et al.
Published: (2015-09-01)

Etanercept (Enbrel®) alternative storage at ambient temperature
by: Shannon E, et al.
Published: (2017-07-01)

ETANERCEPT WITHDRAWAL IN JIA
by: Oana-Maria Farkas, et al.
Published: (2017-06-01)

Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
by: Anna Felis-Giemza, et al.
Published: (2019-10-01)

Safety of Etanercept in the treatment of rheumatic disease patients with Hepatitis C virus infection
by: Lídia Teixeira, et al.
Published: (2018-04-01)

Experience of Applying TNF--inhibitors (Adalimumab and Etanercept) while Treating a Patient with Juvenile Arthritis and Eye Failure
by: T. I. Korovkina
Published: (2015-11-01)

Using etanercept to maintain remission of psoriatic arthritis during pregnancy
by: Ibrahim A Al-Homood, et al.
Published: (2014-01-01)

Etanercept induces remission of polyarteritis nodosa: a case report
by: Maurizio eCapuozzo, et al.
Published: (2014-06-01)

SUCCESSFUL USE OF ETANERCEPT IN A PATIENT WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS WITH AN OVERVIEW OF THE PREDICTORS OF A GOOD RESPONSE TO ONGOING THERAPY
by: Anna V. Karaseva, et al.
Published: (2017-09-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
by: Viola Sacchi, et al.
Published: (2010-06-01)

Etanercept In the treatment of AA-amyloidosis in juvenile rheumatoid arthritis
by: H Mihels
Published: (2004-08-01)

EFFICACY OF ETANERCEPT TREATMENT AS A SECOND TNF α INHIBITOR IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS AND PRIMARY AND SECONDARY INEFFICIENCY OR INTOLERANCE OF INFLIXIMAB
by: E. I. Alexeeva, et al.
Published: (2012-11-01)

Etanercept – A culprit agent in acute pancreatitis?
by: Ferry Gunawan, et al.
Published: (2019-03-01)

Etanercept in the treatment of Graves’ ophthalmopathy with primary hypothyroidism and rheumatoid arthritis
by: Olivera Boskovic, et al.
Published: (2020-01-01)

Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial
by: Josef S. Smolen, et al.
Published: (2018-01-01)

The Effect Of Etanercept Treatment On Serum Malonaldialdehyde Levels In Experimental Endometriosis Rats Model
by: Fatma Ceyla Eraldemir, et al.
Published: (2015-09-01)